APA (7th ed.) Citation

Noto, R. B., Pryma, D. A., Jensen, J., Lin, T., Stambler, N., Strack, T., . . . Goldsmith, S. J. (2018). Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma. The journal of clinical endocrinology and metabolism, 103(1), 213-220. https://doi.org/10.1210/jc.2017-02030

Chicago Style (17th ed.) Citation

Noto, Richard B., Daniel A. Pryma, Jessica Jensen, Tess Lin, Nancy Stambler, Thomas Strack, Vivien Wong, and Stanley J. Goldsmith. "Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic And/or Recurrent Pheochromocytoma or Paraganglioma." The Journal of Clinical Endocrinology and Metabolism 103, no. 1 (2018): 213-220. https://doi.org/10.1210/jc.2017-02030.

MLA (9th ed.) Citation

Noto, Richard B., et al. "Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic And/or Recurrent Pheochromocytoma or Paraganglioma." The Journal of Clinical Endocrinology and Metabolism, vol. 103, no. 1, 2018, pp. 213-220, https://doi.org/10.1210/jc.2017-02030.